Title: The Outcome of Total mesorectal Excision (TME) for the Management of Rectal Cancer
Authors: Dr Mahboobur Rahman, Dr Md. Abdul Hadi, Dr Md. Abul Kalam Azar, Dr Md. Masud Sattar, Dr Sabina Parveen, Dr Md. Mahmudur Rahman
DOI: https://dx.doi.org/10.18535/jmscr/v7i7.80
Abstract
Background: Now a day’s total mesorectal excision (TME). is use as a gold standard technique for middle and lower third of non- disseminated rectal cancer.
Objective: In this study our main aim is to estimate the outcome of total TME for the the management of rectal cancer.
Method: This quasi experimental study was done at The department of General Surgery and Colorectal unit of Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka and Somorita Hospital, Dhaka from July 2005 to June 2007 where patients who having carcinoma involving the middle and lower third of the rectum were evaluated.During the study patients were divided into two groups: Group A: Patients undergone total mesorectal excision (TME) and Group B: Patients undergone conventional operative method. All patients were operated under general anesthesia, placed in Lloyd- Davies position.
Result: in the study one (1.9%) patient of group B received pre-operative chemotherapy. 52 (98.1%) patients of TME: group and similar number patients of Conventional group were received chemotherapy post-operatively. Also, in group A, pelvic pain was present in (5.7%) patient, per rectal bleeding in (1.9%), stomal bleeding (1.9%) and thromboembolic complication in (1.9%) patient. In group B, pelvic pain was in (20.8%) patients, vomiting in (3.8%), thromboembolic complication in (1.9%), wound infection, in (1.9%) patients.
Conclusion: From our result, we can say that total mesorectal excision (TML) is an effective and appropriate operative procedure for the management of middle and lower third of rectal cancer than the conventional technique.
Keyword: Total mesorectal excision (TME), Rectal cancer, Conventional technique.
References
- Arbman G, Nilsson E, Hallbook O, Sjodahl R, 1996, ‘Local rccurrcnce following total mesorectalcxcision for rectal cancer’, British Journal of Surgery, vol. 83, pp. 375-379.
- Enker WE, Thaler HT, Cranor ML, Polyak T, 1995, ‘Total mcsorectal excision is the operative treatment of carcinoma of the rectum’, J Am Coll Surg. vol. 181, no. 4, pp. 335-46.
- Kapiteijn E, van de Velde CJFI, 2000, ‘European trials with Total Mesorectal Excision’, Scm Surg Oncol, vol. 19, pp. 350-357.
- Maurer CA, Z’gragger K, Renzulli P, Schilling MK, NetzerP,Butchler MW,2001 ‘Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery’, British Journal of Surgery, vol. 88, pp. 1501-1505.
- Russell RCG, Norman SW, 2004, Bailey & Loves Short Practice of Surgery, 24thedn, Arnold, London,
- Carlsen E, Schlichting E, Guldvog I, Johnson E, Mcald RJ, 1998, ‘Effect of the introduction of total mesorectal excision for the treatment of rectal cancer', British Journal of Surgery, vol. 85, pp. 526-529.
- Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology. 2004 Aug;232(2):335-46.
- Ridgway PF, Dorzi AW, 2003, ‘The role of total mesorectal excision in the management of rcctal cancer’, Cancer Control, vol. 10, no. 3, pp. 205-11.
- Wibe A, Rcndcdal PR, Svensson E, Norstcin J, Hide TJ, Myrvold III-’, cl a I,2002,‘Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer', British Journal (}f Surgery, vol. 89, pp. 327-334.
- Morgan AF, Finly IG, 2000, ‘Preoperative staging of rectal cancer allows selection of patients for preopcrativc radiotherapy’, British Journal of Surgery vol. 37, pp. 575-579.